Electrophoretic immunoblotting (EIB [Western blotting]) has emerged as the major method for verification of seropositivity for human immunodeficiency virus (HIV) and therefore needs to be thoroughly characterized. The specificities of three EIB systems, our own and two commercial systems, were studied with anticellular sera and serial dilutions of human sera. We demonstrated that in one system, anti-HLA classes I (7, 8, 17) . Obviously, the EIB must itself be very specific but, in addition, highly sensitive.
False-positive reactions in the sensitive present-day human immunodeficiency virus (HIV) antibody-screening tests occur (9-13, 16, 19) , and at least one confirmatory test, usually the electrophoretic immunoblot (EIB [Western blot]), is therefore needed (7, 8, 17) . Obviously, the EIB must itself be very specific but, in addition, highly sensitive.
False-positive results in HIV EIB could be due either to reactions with nonviral molecules or, theoretically, to crossreacting antibodies to hitherto undescribed human retroviruses (3) . Thus, sources of unspecific reactions should be traced. Sensitivity is also important. For example, we need the highest possible sensitivity to prevent transmission from blood donors, and in comparative studies we must find good ways to express sensitivity. In this study, we examined three different EIB methods for detecting antibodies to individual HIV proteins by comparative titrations and quantitative EIB, by the variation of the EIB pattern at different dilutions of serum, and with respect to some factors which can mislead in the interpretation of the EIB.
MATERIALS AND METHODS Sera. There were 10 HIV antibody-positive and 10 antibody-negative control (blood donor) sera used from our diagnostic routine. The criteria of the Centers for Disease Control for classification of patients with acquired immunodeficiency syndrome and related disorders (5) were followed.
The following animal sera against human cellular components were used. Six rabbit anti-HLA class I Rockville, Md.). The latter test involved a biotin-avidin enhancement step. The normal serum dilution in these two systems was 1/100.
Quantification of EIB strips. Quantification methods are elaborated in the accompanying paper (2) . Briefly, for densitometry, a Bio-Rad model 620 video densitometer was used in its reflectance mode. The integrated absorbances are hereafter referred to as color yields and are expressed in color yield units. Color yields were converted to nanograms of IgG by interpolation Ain a standard curve derived from nitrocellulose strips with dots containing known amounts of IgG or from measurements of strips concomitantly developed with known amounts of '25I-labeled anti-HIV IgG.
Initially, we had problems quantifying p53 and p55 separately because occasionally the two molecules were insufficiently separated. The color yields of p53 and p55 were therefore expressed as p53-p55.
RESULTS
Comparison of three EIB systems. (i) Specificity. The specificity of the three EIB systems was tested with human negative control sera and with poly-or monoclonal animal antisera directed against abundant cellular proteins, belonging either to the cytoskeleton or to the cell surface. depicts the degree of reactivity of different animal anticellular sera in the three systems. System A exhibited the strongest reaction with both cytoskeletal and cell surface proteins, although the virus antigen had been prepared by two successive ultracentrifugations in sucrose gradients. Especially notable were the reactions of anti-HLA class I and II sera to proteins migrating closely to HIV gp4l and HIV p31, respectively, as well as reactions of a commercial rabbit antitubulin serum to proteins inseparable from HIV p24 and p55 (Fig. 1) .
Theoretically, the reactions of the anti-HLA sera could be due to a cross-reactivity with viral proteins. We therefore tried to inhibit either the binding of a limiting dilution of rabbit anti-HLA class I and II sera with a large excess of three different human anti-HIV sera or the binding of a limiting dilution of human anti-HIV serum with a large excess of the hyperimmune anti-HLA class I and II sera. In both cases, we controlled the experiments so that the anti-human and -rabbit conjugates did not react appreciably in heterologous crosses with human and rabbit IgG in the EIB and enzyme-linked immunosorbent assay. No inhibition was observed, however (data not shown).
The possibility that antitubulin antibodies could crossreact with HIV gag proteins was explored by use of two (Fig. 2) . At the normal dilutions of 1/400 (system A) and shown photographically (Fig. 3) . We also compared the sensitivity of IgG detection in the three EIB systems by higher than that of the human eye (around 0.03 ng of IgG per with one serum in EIB systems A (A), B (B), and C (C). Abscissa, band in system A). Judged by densitometric analysis of the log2 of serum dilution; ordinate, color yield (ABS) expressed in comparative titrations, the sensitivity of the three routine color yield units.
EIB systems tested was highest for system C, somewhat lower for system B, and lowest for system A. Surprisingly, in all three EIB systems, the endpoint dilutions of the antibodies reactive with p53 and p64 often were higher than those of antibodies reactive with other HIV proteins. These bands have previously not been considered of particular diagnostic value. Recently, they were found to represent antibodies to the reverse transcriptase of HIV (6). In our experience, sera found to react with the screening enzyme-linked immunosorbent assay but diagnosed as falsepositive by the EIB because of the absence of p24, p3l, or gp4l bands often exhibit weak bands in the 50 to 70 kilodalton region. In one case, we saw antibodies to a protein in this range which preceded the other bands by several months (data not shown). Thus, theoretically a few of these reactions could be very weak true-positive cases. The criteria for HIV seropositivity, i.e., clearly visible anti-p24 and antigp4l activity (12, 17) , may have to be revised.
Specificity. The degree of reactivity of anticellular sera was greater in EIB system A than in systems B and C. This indicates that many of the cellular antigens are not tightly bound to virion proteins and can be removed by further purification.
It is well known that antibodies to antigens of the major histocompatibility complex can give false-positive readings in anti-HIV enzyme-linked immunosorbent assays (13, 16) . However, the capacity of the antibodies to mimic antibodies to both virus proteins gp4l (HLA class I) and p31 (HLA class II) bands in the EIB has not to our knowledge been directly demonstrated before. This emphasizes the need for further confirmation of doubtful reactions involving only or mainly these bands. In our experience, EIBs with extracts of uninfected H9 cells are of great help for discriminating antibodies binding to these cell-specific structures from HIV-specific antibodies (data not shown).
The occasional anti-HIV gag activity which we detected in human and animal antisera illustrates the need for adequate control of anti-immunoglobulin-enzyme conjugates. Although very few blood donor sera can give quite strong and seemingly specific anti-gag reactivities (1, 4, 18) at a dilution of 1/100 or higher, the frequency of these falsepositive reactions increases at lower dilutions of serum. The proportion of false-positive reactions also seems to vary with geographical origin (14, 15, 20) . A tentative explanation is that they could be due to infections with yet undiscovered human retroviruses more or less distantly related to HIV.
Pitfalls in HIV serology. In the present paper we have demonstrated a number of factors which can give rise to a false interpretation of HIV EIB. HLA proteins present in most HIV preparations can simulate HIV proteins because of electrophoretic comigration. Human and animal sera used in HIV EIB can give false-positive reactions with gag proteins. This phenomenon is disturbing because in the early stages of HIV infection, anti-gag can be the only visible EIB reaction. We are now studying the causes of this falsepositive reaction.
The variations in EIB pattern with IgG concentration and EIB system create problems for studies of the correlation of EIB pattern with prognosis. This source of variation could, however, be at least partly controlled by the inclusion of a reference serum in each EIB run.
One of the three systems tested had both the highest sensitivity and specificity. We must use the most sensitive and specific verification systems available for maintaining the credibility of blood bank testing, for voluntary screening of concerned individuals, and for diagnostic testing.
